Synaptic vesicle transport and synaptic membrane transporter sites in excitatory amino acid nerve terminals in Alzheimer disease

Journal of Neural Transmission

Volumn 110, Issue 9, 2003, Pages 1013-1027

  Westphalen, R I ^a,b   Scott, H L ^a   Dodd, P R ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Cerebral cortex human; Excitotoxicity; Neurodegeneration; Pathogenesis; Transporters glutamate

Indexed keywords

ASPARTIC ACID; EXCITATORY AMINO ACID; GLUTAMIC ACID; TRITIUM;

ADULT; AGE; AGED; ALZHEIMER DISEASE; ARTICLE; AUTOPSY; BINDING SITE; BRAIN CORTEX; CONTROLLED STUDY; DEATH; HUMAN; HUMAN TISSUE; MEASUREMENT; NERVE ENDING; PRIORITY JOURNAL; SYNAPSE VESICLE; SYNAPTIC MEMBRANE; SYNAPTOSOME; TEMPORAL CORTEX;

AGED; ALZHEIMER DISEASE; ASPARTIC ACID; BINDING SITES; BIOLOGICAL TRANSPORT; CEREBRAL CORTEX; DOWN-REGULATION; EXCITATORY AMINO ACIDS; FEMALE; GLUTAMIC ACID; HUMANS; MALE; MIDDLE AGED; PRESYNAPTIC TERMINALS; RADIOLIGAND ASSAY; SYNAPTIC MEMBRANES; SYNAPTIC VESICLES; TRITIUM;

EID: 0041911085     PISSN: 03009564     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00702-003-0012-z     Document Type: Article

References (54)

1. Beckstrøm H, Julsrud L, Haugeto Ø, Dewar D, Graham DI, Lehre KP, Storm-Mathisen J, Danbolt NC (1999) Interindividual differences in the levels of the glutamate transporters GLAST and GLT, but no clear correlation with Alzheimer's disease. J Neurosci Res 55: 218-229
2. Bellocchio EE, Reimer RJ, Fremeau RTJ, Edwards RH (2000) Uptake of glutamate into synaptic vesicles by an inorganic phosphate transporter. Science 289: 957-960
3. Bürgisser E (1984) Radioligand-receptor binding studies: what's wrong with Scatchard analysis? Trends Pharmacol Sci 5: 142-144
4. Chalmers DT, Dewar D, Graham DI, Brooks DN, McCulloch J (1990) Differential alterations of cortical glutamatergic binding sites in senile dementia of the Alzheimer type. Proc Natl Acad Sci USA 87: 1352-1356
5. Cowburn RF, Hardy JA, Roberts PJ, Briggs R (1988) Regional distribution of pre- and postsynaptic glutamatergic function in Alzheimer's disease. Brain Res 452: 403-407
6. 3H]aspartate binding in cerebral cortex in patients with Alzheimer's and Parkinson's diseases. Neurosci Lett 79: 213-217
7. Danbolt NC (1994) The high affinity uptake system for excitatory amino acids in the brain. Prog Neurobiol 44: 377-396
8. Danbolt NC (2001) Glutamate uptake. Prog Neurobiol 65: 1-105
9. +-dependent "binding" of D-aspartate in brain membranes is largely due to uptake into membrane-bounded saccules. J Neurochem 47: 819-824
10. de Boni U, Crapper-McLachlan DR (1985) Controlled induction of paired helical filaments of the Alzheimer type in cultured human neurons, by glutamate and aspartate. J Neurol Sci 68: 105-118
11. Doble A (1999) The role of excitotoxicity in neurodegenerative disease: implications for therapy. Pharmacol Ther 81: 163-221
12. Dodd PR, Hardy JR, Oakley AE, Edwardson JA, Perry EK, Delaunoy J-P (1981) A rapid method for preparing synaptosomes: comparison with alternative procedures. Brain Res 226: 107-118
13. Dodd PR, Hardy JA, Baig EB, Kidd AM, Bird ED, Watson WEJ, Johnston GAR (1986) Optimization of freezing, storage, and thawing conditions for the preparation of metabolically active synaptosomes from frozen rat and human brain. Neurochem Pathol 4: 177-198
14. Dodd PR, Watson WEJ, Morrison MM, Johnston GAR, Bird ED, Cowburn RF, Hardy JA (1989) Uptake of γ-aminobutyric acid and L-glutamic acid by synaptosomes from postmortem human cerebral cortex: multiple sites, sodium dependence and effect of tissue preparation. Brain Res 490: 320-331
15. Dodd PR, Thomas GJ, Harper CG, Kril JJ (1992) Amino acid neurotransmitter receptor changes in cerebral cortex in alcoholism: effect of cirrhosis of the liver. J Neurochem 59: 1506-1515
16. Fleck MW, Barrionuevo G, Palmer AM (2001a) Release of D,L-threo-β-hydroxyaspartate as a false transmitter from excitatory amino acid-releasing nerve terminals. Neurochem Int 39: 75-81
17. Fleck MW, Barrionuevo G, Palmer AM (2001b) Synaptosomal and vesicular accumulation of L-glutamate, L-aspartate and D-aspartate. Neurochem Int 39: 217-225
18. Fykse EM, Iversen EG, Fonnum F (1992) Inhibition of L-glutamate uptake into synaptic vesicles. Neurosci Lett 135: 125-128
19. Greenamyre JT, Young AB (1989) Excitatory amino acids and Alzheimer's disease. Neurobiol Aging 10: 593-602
20. Gundersen V, Chaudhry FA, Bjaalie JG, Fonnum F, Ottersen OP, Storm-Mathisen J (1998) Synaptic vesicular localization and exocytosis of L-aspartate in excitatory nerve terminals: a quantitative immunogold analysis in rat hippocampus. J Neurosci 18: 6059-6070
21. Hardy JA, Dodd PR (1983) Metabolic and functional studies on post-mortem human brain. Neurochem Int 5: 253-266
22. Hardy JA, Barton AJL, Lofdahl E, Cheetham SC, Johnston GAR, Dodd PR (1986) Uptake of γ-aminobutyric acid and glycine by synaptosomes from postmortem human brain. J Neurochem 47: 460-467
23. Hardy JA, Cowburn RF, Barton AJL, Reynolds GP, Lofdahl E, O'Carroll A-M, Wester P, Winblad B (1987) Region-specific loss of glutamate innervation in Alzheimer's disease. Neurosci Lett 73: 77-80
24. Hyman BT, van Hoesen GW, Damasio AR, Barnes CL (1984) Alzheimer's disease: cell-specific pathology isolates the hippocampal formation. Science 225: 1168-1170
25. Hyman BT, van Hoesen GW, Damasio AR (1987) Alzheimer's disease: glutamate depletion in the hippocampal perforant pathway zone. Ann Neurol 22: 37-40
26. Khachaturian ZS (1985) Diagnosis of Alzheimer's disease. Arch Neurol 42: 1097-1105
27. Kirvell SL, Fremeau RT, Francis PT (2002) Vesicular glutamate transporter 1 in Alzheimer's disease. Soc Neurosci 2002 Abstr Viewer 785.15 (Abstract)
28. Kish PE, Ueda T (1989) Glutamate accumulation into synaptic vesicles. Meth Enzymol 174: 9-25
29. Li S, Mallory M, Alford M, Tanaka S, Masliah E (1997) Glutamate transporter alterations in Alzheimer disease are possibly associated with abnormal APP expression. J Neuropathol Exp Neurol 56: 901-911
30. Lowe SL, Bowen DM, Francis PT, Neary D (1990) Ante mortem cerebral amino acid concentrations indicate selective degeneration of glutamate-enriched neurons in Alzheimer's disease. Neuroscience 38: 571-577
31. Lynch M, Walsh B (1998) Genetics and analysis of quantitative traits. Sinauer Associates Inc, Sunderland, MA, USA
32. Mann DMA, Yates PO, Marcyniuk B (1985) Some morphometric observations on the cerebral cortex and hippocampus in presenile Alzheimer's disease, senile dementia of Alzheimer type and Down's syndrome in middle age. J Neurol Sci 69: 139-159
33. Markwell MA, Haas SM, Bieber LL, Tolbert NE (1978) A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal Biochem 87: 206-210
34. Masliah E, Alford M, Deteresa R, Mallory M, Hansen L (1996) Deficient glutamate transport is associated with neurodegeneration in Alzheimer's disease. Ann Neurol 40: 759-766
35. Mortensen M, Dodd PR (1999) The modulatory effect of spermine on the glutamate-NMDA receptor is regionally variable in normal human adult cerebral cortex. Pharmacol Toxicol 84: 135-142
36. Mountjoy CQ, Roth M, Evans NJ, Evans HM (1983) Cortical neuronal counts in normal elderly controls and demented patients. Neurobiol Aging 4: 1-11
37. Naito S, Ueda T (1985) Characterization of glutamate uptake into synaptic vesicles. J Neurochem 44: 99-109
38. Nordberg A (1992) Neuroreceptor changes in Alzheimer disease. Cerebrovasc Brain Metab Rev 4: 303-328
39. Ottersen OP, Storm-Mathisen J, Bramham C, Torp R, Laake JH, Gundersen V (1990) A quantitative electron microscopic immunocytochemical study of the distribution and synaptic handling of glutamate in rat hippocampus. Prog Brain Res 83: 99-114
40. Palmer AM, Procter AW, Stratmann GC, Bowen DM (1986) Excitatory amino acid-releasing and cholinergic neurones in Alzheimer's disease. Neurosci Lett 66: 199-204
41. 3H] glutamate to repeatedly frozen-thawed rat brain membranes. Neurochem Int 11: 69-75
42. Perry TL, Hansen S, Gandham SS (1981) Postmortem changes of amino compounds in human and rat brain. J Neurochem 36: 406-410
43. Procter AW, Palmer AM, Francis PT, Lowe SL, Neary D, Murphy E, Doshi R, Bowen DM (1988) Evidence of glutamatergic denervation and possible abnormal metabolism in Alzheimer's disease. J Neurochem 50: 790-802
44. NMDA receptor is differentially responsive to conantokins in normal and Alzheimer disease human cerebral cortex. J Neurochem 81: 765-779
45. Roseth S, Fykse EM, Fonnum F (1995) Uptake of L-glutamate into rat brain synaptic vesicles: effect of inhibitors that bind specifically to the glutamate transporter. J Neurochem 65: 96-103
46. Rothman SM, Olney JW (1986) Glutamate and the pathophysiology of hypoxic-ischemic brain damage. Ann Neurol 19: 105-111
47. Sasaki H, Muramoto O, Kanazawa I, Arai H, Kosaka K, Iizuka R (1986) Regional distribution of amino acid transmitters in postmortem brains of presenile and senile dementia of Alzheimer type. Ann Neurol 19: 263-269
48. Scott HL, Tannenberg AEG, Dodd PR (1995) Variant forms of neuronal glutamate transporter sites in Alzheimer's disease cerebral cortex. J Neurochem 64: 2193-2202
49. Scott HL, Pow DV, Tannenberg AEG, Dodd PR (2002) Aberrant expression of the glutamate transporter excitatory amino acid transporter 1 (EAAT1) in Alzheimer's disease. J Neurosci 22: RC206 (1-5)
50. 3H]TCP binding sites in Alzheimer's disease brains. Brain Res 462: 76-82
51. Smith CCT, Bowen DM, Sims NR, Neary D, Davison AN (1983) Amino acid release from biopsy samples of temporal neocortex from patients with Alzheimer's disease. Brain Res 264: 138-141
52. Suchak SK, Baloyianni NV, Perkinton MS, Williams RJ, Meldrum BS, Rattray M (2003) The 'glial' glutamate transporter, EAAT2 (Glt-1) accounts for high affinity glutamate uptake into adult rodent nerve endings. J Neurochem 84: 522-532
53. Wilkinson L, Hill M, Vang E (1992) SYSTAT: Statistics. SYSTAT Inc., Evanston, IL
54. Winer BJ, Brown DR, Michels KM (1991) Statistical principles in experimental design. McGraw-Hill, Sydney, NSW